Indications and uses
Temporary relief of difficult respiration, headaches, skin eruptions, nausea.
Tox-Chord
- Manufacturer
- Energetix Corp | Apotheca Company
- Effective date
- 2017-03-16
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 4
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 01:17:30
Label at a glance#
ProductTox-Chord
Active ingredientALFALFA, ALUMINUM OXIDE, BENZOIC ACID, D&C BLACK NO. 2, CETRARIA ISLANDICA SUBSP. ISLANDICA, ESTRONE, FUCUS VESICULOSUS, FUMARIC ACID, PORK LIVER, POTASSIUM CARBONATE, WOOD CREOSOTE, SODIUM CHLORIDE, PARAFFIN, KEROSENE, PHOSPHORIC ACID, PHOSPHORUS, PINE TAR, PLANTAGO MAJOR, LEAD, PULSATILLA VULGARIS, RADIUM BROMIDE, RESORCINOL, PHENYL SALICYLATE, SILICON DIOXIDE, COMFREY ROOT, TOBACCO LEAF, TURPENTINE OIL, THYROID, BOVINE, ELYMUS REPENS ROOT, ZINC OXIDE
Label structure9 sections
Dosage and administration
Take 30 drops orally twice daily or as directed by a healthcare professional. Consult a physician for use in children under 12 years of age or if symptoms worsen or persist.
Contacts and useful links#
Label contents#
Full prescribing information#
ACTIVE INGREDIENTS:
Alfalfa 4X; Alumina 18X; Benzoicum acidum 18X; Carboneum 18X; Cetraria islandica 9C; Folliculinum 18X; Fucus vesiculosus 5X; Fumaricum acidum 18X; Hepar suis 9X; 12X; 6C; Kali carbonicum 12X; Kreosotum 18X; Natrum muriaticum 12X; Paraffinum 18X; Petroleum 18X; Phosphoricum acidum 12X; Phosphorus 12X; Pix liquida 18X; Plantago major 4X; Plumbum metallicum 15X; Pulsatilla (Vulgaris) 12X; Radium bromatum 15C; Resorcinum 18X; Salol 18X; Silicea 12X; Symphytum officinale 4X; Tabacum 30X; Terebinthina 18X; Thyroidinum (Bovine) 9X; 12X; Triticum repens 4X; Zincum oxydatum 18X.
PURPOSE:
Temporary relief of difficult respiration, headaches, skin eruptions, nausea.
WARNINGS:
In case of overdose, get medical help or call a Poison Control Center right away.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children.
Other Information
Store in cool, dry place out of direct sunlight.
Do not use if neck wrap is broken or missing.
KEEP OUT OF REACH OF CHILDREN:
Keep out of reach of children. In case of overdose, contact physician or Poison Control Center right away.
DIRECTIONS:
Take 30 drops orally twice daily or as directed by a healthcare professional.
Consult a physician for use in children under 12 years of age or if symptoms worsen or persist.
USES:
Temporary relief of difficult respiration, headaches, skin eruptions, nausea.
INACTIVE INGREDIENTS:
Ethyl Alcohol, Glycerin, Purified Water
QUESTIONS:
Distributed by
Energetix Corp
Dahlonega, GA 30533
Questions? 800.990.7085
PACKAGE LABEL DISPLAY:
energetix
Tox-Chord
Homeopathic Remedy
Difficult respiration, headaches,
skin eruptions, nausea.
2 fl oz (59.1 mL)
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ALFALFA | ACTIVE INGREDIENT | DJO934BRBD | 1 | |
| ALUMINUM OXIDE | ACTIVE INGREDIENT | LMI26O6933 | 1 | |
| ANEMONE PULSATILLA WHOLE | ACTIVE INGREDIENT | I76KB35JEV | 1 | |
| BENZOIC ACID | ACTIVE INGREDIENT | 8SKN0B0MIM | 1 | |
| CETRARIA ISLANDICA SUBSP. ISLANDICA | ACTIVE INGREDIENT | BJ7YPN79A1 | 1 | |
| COMFREY ROOT | ACTIVE INGREDIENT | M9VVZ08EKQ | 1 | |
| D&C BLACK NO. 2 | ACTIVE INGREDIENT | 4XYU5U00C4 | 1 | |
| ELYMUS REPENS ROOT | ACTIVE INGREDIENT | 3IXW0F6P8W | 1 | |
| ESTRONE | ACTIVE INGREDIENT | 2DI9HA706A | 1 | |
| FUCUS VESICULOSUS | ACTIVE INGREDIENT | 535G2ABX9M | 1 | |
| FUMARIC ACID | ACTIVE INGREDIENT | 88XHZ13131 | 1 | |
| KEROSENE | ACTIVE INGREDIENT | 1C89KKC04E | 1 | |
| LEAD | ACTIVE INGREDIENT | 2P299V784P | 1 | |
| PARAFFIN | ACTIVE INGREDIENT | I9O0E3H2ZE | 1 | |
| PHENYL SALICYLATE | ACTIVE INGREDIENT | 28A37T47QO | 1 | |
| PHOSPHORIC ACID | ACTIVE INGREDIENT | E4GA8884NN | 1 | |
| PHOSPHORUS | ACTIVE INGREDIENT | 27YLU75U4W | 1 | |
| PINE TAR | ACTIVE INGREDIENT | YFH4WC535J | 1 | |
| PLANTAGO MAJOR | ACTIVE INGREDIENT | W2469WNO6U | 1 | |
| PORK LIVER | ACTIVE INGREDIENT | 6EC706HI7F | 1 | |
| POTASSIUM CARBONATE | ACTIVE INGREDIENT | BQN1B9B9HA | 1 | |
| RADIUM BROMIDE | ACTIVE INGREDIENT | R74O7T8569 | 1 | |
| RESORCINOL | ACTIVE INGREDIENT | YUL4LO94HK | 1 | |
| SILICON DIOXIDE | ACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| SODIUM CHLORIDE | ACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| THYROID, BOVINE | ACTIVE INGREDIENT | MN18OTN73W | 1 | |
| TOBACCO LEAF | ACTIVE INGREDIENT | 6YR2608RSU | 1 | |
| TURPENTINE OIL | ACTIVE INGREDIENT | C5H0QJ6V7F | 1 | |
| WOOD CREOSOTE | ACTIVE INGREDIENT | 3JYG22FD73 | 1 | |
| ZINC OXIDE | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| ALFALFA | ACTIVE MOIETY | DJO934BRBD | 1 | |
| ALUMINUM OXIDE | ACTIVE MOIETY | LMI26O6933 | 1 | |
| ANEMONE PULSATILLA WHOLE | ACTIVE MOIETY | I76KB35JEV | 1 | |
| BENZOIC ACID | ACTIVE MOIETY | 8SKN0B0MIM | 1 | |
| CARBONATE ION | ACTIVE MOIETY | 7UJQ5OPE7D | 1 | |
| CETRARIA ISLANDICA SUBSP. ISLANDICA | ACTIVE MOIETY | BJ7YPN79A1 | 1 | |
| CHLORIDE ION | ACTIVE MOIETY | Q32ZN48698 | 1 | |
| COLLOIDAL SILICON DIOXIDE | ACTIVE MOIETY | ETJ7Z6XBU4 | 1 | |
| COMFREY ROOT | ACTIVE MOIETY | M9VVZ08EKQ | 1 | |
| D&C BLACK NO. 2 | ACTIVE MOIETY | 4XYU5U00C4 | 1 | |
| ELYMUS REPENS ROOT | ACTIVE MOIETY | 3IXW0F6P8W | 1 | |
| ESTRONE | ACTIVE MOIETY | 2DI9HA706A | 1 | |
| FUCUS VESICULOSUS | ACTIVE MOIETY | 535G2ABX9M | 1 | |
| FUMARIC ACID | ACTIVE MOIETY | 88XHZ13131 | 1 | |
| KEROSENE | ACTIVE MOIETY | 1C89KKC04E | 1 | |
| LEAD | ACTIVE MOIETY | 2P299V784P | 1 | |
| PARAFFIN | ACTIVE MOIETY | I9O0E3H2ZE | 1 | |
| PHENYL SALICYLATE | ACTIVE MOIETY | 28A37T47QO | 1 | |
| PHOSPHORIC ACID | ACTIVE MOIETY | E4GA8884NN | 1 | |
| PHOSPHORUS | ACTIVE MOIETY | 27YLU75U4W | 1 | |
| PINE TAR | ACTIVE MOIETY | YFH4WC535J | 1 | |
| PLANTAGO MAJOR | ACTIVE MOIETY | W2469WNO6U | 1 | |
| PORK LIVER | ACTIVE MOIETY | 6EC706HI7F | 1 | |
| RADIUM CATION | ACTIVE MOIETY | 05456MVL7T | 1 | |
| RESORCINOL | ACTIVE MOIETY | YUL4LO94HK | 1 | |
| THYROID, BOVINE | ACTIVE MOIETY | MN18OTN73W | 1 | |
| TOBACCO LEAF | ACTIVE MOIETY | 6YR2608RSU | 1 | |
| TURPENTINE OIL | ACTIVE MOIETY | C5H0QJ6V7F | 1 | |
| WOOD CREOSOTE | ACTIVE MOIETY | 3JYG22FD73 | 1 | |
| ZINC CATION | ACTIVE MOIETY | 13S1S8SF37 | 1 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- Tox-Chord
- Alfalfa, Alumina, Benzoicum Acidum, Carboneum, Cetraria Islandica, Folliculinum, Fucus Vesiculosus, Fumaricum Acidum, Hepar Suis, Kali Carbonicum, Kreosotum, Natrum Muriaticum, Paraffinum, Petroleum, Phosphoricum Acidum, Phosphorus, Pix Liquida, Plantago Major, Plumbum Metallicum, Pulsatilla (Vulgaris), Radium Bromatum, Resorcinum, Salol, Silicea, Symphytum Officinale, Tabacum, Terebinthina, Thyroidinum (Bovine), Triticum Repens, Zincum Oxydatum
- ALFALFA
- ALUMINUM OXIDE
- BENZOIC ACID
- D&C BLACK NO. 2
- CETRARIA ISLANDICA SUBSP. ISLANDICA
- ESTRONE
- FUCUS VESICULOSUS
- FUMARIC ACID
- PORK LIVER
- POTASSIUM CARBONATE
- CARBONATE ION
- WOOD CREOSOTE
- SODIUM CHLORIDE
- CHLORIDE ION
- PARAFFIN
- KEROSENE
- PHOSPHORIC ACID
- PHOSPHORUS
- PINE TAR
- PLANTAGO MAJOR
- LEAD
- PULSATILLA VULGARIS
- ANEMONE PULSATILLA
- RADIUM BROMIDE
- RADIUM CATION
- RESORCINOL
- PHENYL SALICYLATE
- SILICON DIOXIDE
- COMFREY ROOT
- TOBACCO LEAF
- TURPENTINE OIL
- THYROID, BOVINE
- ELYMUS REPENS ROOT
- ZINC OXIDE
- ZINC CATION
- WATER
- ALCOHOL
- GLYCERIN
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 64578-0122 | 64578-0122-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ALFALFA | DJO934BRBD | ACTIB |
| ALUMINUM OXIDE | LMI26O6933 | ACTIB |
| BENZOIC ACID | 8SKN0B0MIM | ACTIB |
| D&C BLACK NO. 2 | 4XYU5U00C4 | ACTIB |
| CETRARIA ISLANDICA SUBSP. ISLANDICA | BJ7YPN79A1 | ACTIB |
| ESTRONE | 2DI9HA706A | ACTIB |
| FUCUS VESICULOSUS | 535G2ABX9M | ACTIB |
| FUMARIC ACID | 88XHZ13131 | ACTIB |
| PORK LIVER | 6EC706HI7F | ACTIB |
| POTASSIUM CARBONATE | BQN1B9B9HA | ACTIB |
| WOOD CREOSOTE | 3JYG22FD73 | ACTIB |
| SODIUM CHLORIDE | 451W47IQ8X | ACTIB |
| PARAFFIN | I9O0E3H2ZE | ACTIB |
| KEROSENE | 1C89KKC04E | ACTIB |
| PHOSPHORIC ACID | E4GA8884NN | ACTIB |
| PHOSPHORUS | 27YLU75U4W | ACTIB |
| PINE TAR | YFH4WC535J | ACTIB |
| PLANTAGO MAJOR | W2469WNO6U | ACTIB |
| LEAD | 2P299V784P | ACTIB |
| PULSATILLA VULGARIS | I76KB35JEV | ACTIB |
| RADIUM BROMIDE | R74O7T8569 | ACTIB |
| RESORCINOL | YUL4LO94HK | ACTIB |
| PHENYL SALICYLATE | 28A37T47QO | ACTIB |
| SILICON DIOXIDE | ETJ7Z6XBU4 | ACTIB |
| COMFREY ROOT | M9VVZ08EKQ | ACTIB |
| TOBACCO LEAF | 6YR2608RSU | ACTIB |
| TURPENTINE OIL | C5H0QJ6V7F | ACTIB |
| THYROID, BOVINE | MN18OTN73W | ACTIB |
| ELYMUS REPENS ROOT | 3IXW0F6P8W | ACTIB |
| ZINC OXIDE | SOI2LOH54Z | ACTIM |
| WATER | 059QF0KO0R | IACT |
| ALCOHOL | 3K9958V90M | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / PERIODONTAL | 0.53 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAMUSCULAR | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | 32400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / ORAL | 26208 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1720 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY, METERED / NASAL | 13 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / OPHTHALMIC | 58 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE / ORAL | 3487 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / OPHTHALMIC | 6 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | 2000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SHAMPOO / TOPICAL | 5 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, EMULSION / INTRAVENOUS | 24100 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 6f3ec2ef-bda8-4caf-814a-7ab0ef3fa0eb | 49a09299-98fe-41ab-9e58-e86cd7e5929d | 2017-03-16 | Warnings | 6f3ec2ef-bda8-4caf-814a-7ab0ef3fa0eb 49a09299-98fe-41ab-9e58-e86cd7e5929d |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.